Celularity Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Celularity Inc. on August 27, 2024. The filing primarily addresses corporate governance changes, specifically the appointment of a new director to the Board of Directors and a reduction in the total number of directors.
Key Financial Metrics
The filing text does not provide revenue, profit, cash flow, margins, debt, or liquidity figures. This report focuses on personnel and governance events rather than financial performance.
Material Changes
- Director Appointment: Richard J. Berman was appointed as a Class II director to fill the vacancy left by the resignation of Robin L. Smith, M.D. He serves until his successor is elected or until an earlier termination event.
- Committee Assignment: Mr. Berman was appointed to the Audit Committee effective immediately and is deemed independent under Nasdaq listing requirements.
- Board Size Reduction: Following the departure of Marc Mazur, the Board resolved to reduce the total number of directors from seven to six. Additionally, the number of directors in Class III (terms expiring in 2024) was reduced from two to one.
Compensation and Governance Details
Mr. Berman received compensation in accordance with the company's non-employee director practices:
- Equity Grant: An option to purchase 118,111 shares of Class A common stock with a grant date value of $300,000.
- Exercise Price: $3.01 per share (closing price on August 27, 2024).
- Vesting Schedule: Three successive equal annual installments, subject to continuous service.
- Term: 10 years.
- Indemnification: A standard indemnification agreement was executed.
Investor Verification Checklist
- Verify the independence status of Richard J. Berman regarding the Audit Committee.
- Review the definitive proxy statement for the 2023 Annual Meeting to confirm the full details of the non-employee director compensation plan.
- Confirm the updated composition of the Board of Directors and the specific terms of the remaining Class III directors.
- Check for any subsequent filings regarding the resignation of Robin L. Smith or Marc Mazur for additional context on the departures.